PENTA-GEMFIBROZIL DIN 02229604

Status: Cancelled (Unreturned Annual)

Holder: PENTAPHARM LTD.

Health Canada record

Active ingredient(s)	GEMFIBROZIL 600 MG
Dosage form	Tablet
Route	Oral
Schedule
Class	Human
ATC
Original market date
Current status date	05-Apr-2018
Source	Health Canada DPD

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing GEMFIBROZIL

DIN	Product	Company	Form	Strength	Status
02142074	TEVA-GEMFIBROZIL	TEVA CANADA LIMITED	Tablet	GEMFIBROZIL 600 MG	Marketed
01979582	APO-GEMFIBROZIL	APOTEX INC	Tablet	GEMFIBROZIL 600 MG	Cancelled Post Market
01979574	APO-GEMFIBROZIL CAP 300MG USP	APOTEX INC	Capsule	GEMFIBROZIL 300 MG	Cancelled Post Market
02241608	DOM-GEMFIBROZIL	DOMINION PHARMACAL	Capsule	GEMFIBROZIL 300 MG	Cancelled Post Market
02230580	DOM-GEMFIBROZIL	DOMINION PHARMACAL	Tablet	GEMFIBROZIL 600 MG	Cancelled Post Market
00851922	GEMFIBROZIL CAP 300MG	OMNI LABORATORIES DIVISION, WARNER-LAMBERT CANADA INC.	Capsule	GEMFIBROZIL 300 MG	Cancelled Post Market
00851930	GEMFIBROZIL TAB 600MG	OMNI LABORATORIES DIVISION, WARNER-LAMBERT CANADA INC.	Tablet	GEMFIBROZIL 600 MG	Cancelled Post Market
02136031	GEMFIBROZIL-300 - CAP	PRO DOC LIMITEE	Capsule	GEMFIBROZIL 300 MG	Cancelled Post Market
02136058	GEMFIBROZIL-600 - TAB 600MG	PRO DOC LIMITEE	Tablet	GEMFIBROZIL 600 MG	Cancelled Post Market
00659606	LOPID 600MG	PFIZER CANADA ULC	Tablet	GEMFIBROZIL 600 MG	Cancelled Post Market
00599026	LOPID CAP 300MG	PFIZER CANADA ULC	Capsule	GEMFIBROZIL 300 MG	Cancelled Post Market
02185407	MYLAN-GEMFIBROZIL	MYLAN PHARMACEUTICALS ULC	Capsule	GEMFIBROZIL 300 MG	Cancelled Post Market
02230476	MYLAN-GEMFIBROZIL	MYLAN PHARMACEUTICALS ULC	Tablet	GEMFIBROZIL 600 MG	Cancelled Post Market
02058456	NU-GEMFIBROZIL CAP 300MG	NU-PHARM INC	Capsule	GEMFIBROZIL 300 MG	Cancelled Post Market
02058464	NU-GEMFIBROZIL TAB 600MG	NU-PHARM INC	Tablet	GEMFIBROZIL 600 MG	Cancelled Post Market
02254867	PHL-GEMFIBROZIL	PHARMEL INC	Tablet	GEMFIBROZIL 600 MG	Cancelled Post Market
02254859	PHL-GEMFIBROZIL	PHARMEL INC	Capsule	GEMFIBROZIL 300 MG	Cancelled Post Market
02230183	PMS-GEMFIBROZIL	PHARMASCIENCE INC	Tablet	GEMFIBROZIL 600 MG	Cancelled Post Market
02239951	PMS-GEMFIBROZIL	PHARMASCIENCE INC	Capsule	GEMFIBROZIL 300 MG	Cancelled Post Market
02242126	RIVA-GEMFIBROZIL	LABORATOIRE RIVA INC.	Tablet	GEMFIBROZIL 600 MG	Cancelled Post Market
02242390	SCHEINPHARM GEMFIBROZIL	SCHEIN PHARMACEUTICAL CANADA INC.	Capsule	GEMFIBROZIL 300 MG	Cancelled Post Market
02241704	TEVA-GEMFIBROZIL	TEVA CANADA LIMITED	Capsule	GEMFIBROZIL 300 MG	Cancelled Post Market

Notices of Compliance

NOC	Date	Submission	Reason
4432	1996-10-02	New Drug Submission (NDS)

International API supply for GEMFIBROZIL

4 valid EDQM Certificates of Suitability from 4 holders. 8 active FDA Drug Master Files.

Request a quote for PENTA-GEMFIBROZIL

How to read a Canadian DIN record